Category Archives: Drug use behaviours/harm reduction
What is the effectiveness of supervised injection services?
2014
Key take-home messages The use of supervised injection services can lead to reductions in injecting behaviour and an increase in the number of clients accessing addiction treatment services. Supervised injection...
Crystal methamphetamine use, sexual risk behaviours and harm reduction among men who have sex with men
2015
Key take-home messages Use of crystal methamphetamine among men who have sex with men has been linked to unprotected sex, sex with multiple partners, sex with partners of unknown serostatus,...
HIV and STI testing among Indigenous women and women who inject drugs
2016
Key take-home messages Rates of HIV and other sexually transmitted and bloodborne infections are high among Indigenous women and women who inject drugs. For women who use drugs, centres that...
Chest compressions and rescue breathing when administering naloxone in opioid overdose
2016
Key take-home messages Opioid overdoses cause respiratory failure (a reduction or stop in breathing), which can lead to cardiac arrest. In the event of a suspected opioid overdose, bystanders should...
Engaging law enforcement in harm reduction programs for people who inject drugs
2016
Key take-home messages Injection drug use is a major contributor to the spread of HIV and Hepatitis C in Canada. Laws and policing practices that govern injection drug use influence...
NARCAN® Nasal Spray efficacy for emergency treatment of opioid overdose
2018
Key take-home messages The administration of ready-to-use, needle-free concentrated NARCAN® Nasal Spray (containing 4mg of naloxone hydrochloride in low volume of 0.1 mL) results in pharmacokinetic parameters that either equal...
HIV prevalence and correlations in prisons in different regions of the world: A review article
2018
The prevalence of HIV is substantially higher among prisoners than the general population, while the incidence varies considerably in different regions around the world. If we consider Sub-Saharan Africa as...
Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review
2018
BACKGROUND: Injection drug use (IDU) in nonurban areas of the United States is a growing public health concern, but there has been no comprehensive assessment of existing research on injection-related...
Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV?
2018
PURPOSE OF REVIEW: To describe models of integrated and co-located care for opioid use disorder (OUD), hepatitis C (HCV), and HIV. RECENT FINDINGS: The design and scale-up of multidisciplinary care...
Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact
2018
BACKGROUND: Needle and syringe program (NSP) service delivery models encompass fixed sites, mobile services, vending machines, pharmacies, peer NSPs, street outreach, and inter-organizational agreements to add NSP services to other...
HIV and viral hepatitis among imprisoned key populations
2018
Prisons and other closed facilities create opportunities for transmission of human immunodeficiency virus (HIV) and viral hepatitis during detention and after release. We conducted a systematic review and meta-analysis of...
Health outcomes for clients of needle and syringe programs in prisons
2018
High levels of drug dependence have been observed in the prison population globally, and the sharing of injecting drug equipment in prisons has contributed to higher prevalence of bloodborne diseases...
